MedPath

EFFECTIVENESS OF FUROSEMIDE IN CONTINUOUS INFUSION VS ethacrynic acid IN CONTINUOUS INFUSION IN CHILDREN SUBJECT TO A heart surgery of age LESS THAN 10 YEARS

Conditions
ALL CHILDREN AGE 'LESS THAN 10 YEARS OF AGE' WITH CONGENITAL HEART PROCEDURE SUBJECT TO cardiac surgery in whom the diuretic ARE GIVEN IN ACCORDANCE WITH THE FOLLOWING CONTINUOUS INFUSION PROTOCOL Cardiac surgery with clamping> 90 minutes Interventions interventional cardiology with hybrid approach and inotropic score> 20 after the procedure Capillary leak syndrome postoperative and / or signs of fluid overload
MedDRA version: 14.1Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disorders
Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Registration Number
EUCTR2012-004343-80-IT
Lead Sponsor
OSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
100
Inclusion Criteria

ALL CHILDREN AGE 'LESS THAN 10 YEARS OF AGE' WITH CONGENITAL HEART PROCEDURE SUBJECT TO cardiac surgery in whom the diuretic ARE GIVEN IN ACCORDANCE WITH THE FOLLOWING CONTINUOUS INFUSION PROTOCOL Cardiac surgery with clamping> 90 minutes Interventions interventional cardiology with hybrid approach and inotropic score> 20 after the procedure Capillary leak syndrome postoperative and / or signs of fluid overload
Are the trial subjects under 18? yes
Number of subjects for this age range: 100
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- PREOPERATIVE RENAL DYSFUNCTION - DIURETICS INFUSION OF HIGH-DOSE FOR EXTENDED PERIODS (more than one week) DURING PREOPERATIVE - NOTE A dialysis Extracorporeal ARRIVAL IN ICT - A STATEMENT IN PERITONEAL DIALYSIS PATIENTS IN ALL OLIGOANURICO 'ARRIVAL IN ICT - NOTE A Extracorporeal membrane oxygenation ARRIVAL IN ICT

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath